News
Ahead of the company’s second-quarter earnings call Aug. 6, Oscar Health is slashing its full-year guidance by about half a ...
Oscar Health, Inc. ("Oscar" or the "Company") (NYSE: OSCR), a leading healthcare technology company, announced today certain ...
2d
Asianet Newsable on MSNOscar Health Now Expects Loss From Operations Of $200M To $300M In 2025: Here’s What Retail Thinks About The Stock Price
The company announced that it now expects a loss from operations of approximately $230 million and a net loss of roughly $228 ...
1d
TipRanks on MSNModerately bullish activity in Oscar Health with shares up 1.8%
Moderately bullish activity in Oscar Health (OSCR), with shares up 26c, or 1.8%, near $14.96. Options volume roughly in line with average with ...
Oscar's strong revenue growth, improving profitability, and efficient SG&A management support my positive outlook. Read why ...
Oscar Health (NYSE:OSCR) stock fell 3.5% after the healthcare technology company revised its 2025 financial guidance following a review of second quarter Marketplace data that revealed ...
The health insurance agency said Tuesday it now expects a medical loss ratio of 86% to 87% for the full year, with total revenue now seen at $12 billion to $12.2 billion and a loss from operations of ...
Is OSCR in Good Health? Oscar Health (NYSE:OSCR) is a technology-driven health insurance company specializing in individual, ...
Investing.com -- Oscar Health has increased its full-year revenue forecast to between $12 billion and $12.2 billion, up from its previous guidance of $11.20 billion to $11.30 billion. This new outlook ...
Oscar Health earlier this year filed for an initial public offering. On Friday Aug. 13, the health ... More insurer said it would expand to three new states to sell coverage for 2022.
Oscar Health CEO Mario Schlosser speaks at the 2017 Best in the Business Awards at Trianon Ballroom ... More at The New York Hilton Midtown on November 9, 2017 in New York City.
Oscar Health, Clover Health and Bright Health entered the public markets as the COVID-19 pandemic disrupted how care was delivered. Investors interest in digital health tools was as high as it had ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results